Chugai Pharmaceuticals (4519-TO)

QUOTE AND NEWS
FierceBiotech  Aug 25  Comment 
The news that Roche struck a deal to buy InterMune for $8.3 billion reportedly came at the expense of Chugai's investors.
TheStreet.com  Aug 18  Comment 
NEW YORK (TheStreet) -- Shares ofaChugai Pharmaceutica are down -4.65% to $75.40 after the company denied reports that its parent Roche Holding awas in talks to buy out the Japanese drugmaker to secure full control of its cancer and arthritis...
Wall Street Journal  Aug 18  Comment 
Cash-rich Roche is reportedly eyeing a $10 billion deal to take full control of Chugai Pharmaceutical. That may reflect a dearth of attractive opportunities elsewhere.
TheStreet.com  Aug 18  Comment 
NEW YORK (The Deal) -- Despite a denial from the target and silence from the potential suitor, shares of Japanese drug company Chugai Pharmaceuticalacontinue to climb as investors bet on the years-long consolidation of global drugmakers. Chugai's...
Reuters  Aug 18  Comment 
(Adds Chugai Pharmaceuticals, Dollar General, Sensata, Ingersoll-Rand and Mexichem)
MarketWatch  Aug 18  Comment 
Shares of Roche Holding AG rose 1.6% in European trade Monday following reports that the Swiss drug maker is in talks to take over the rest of the shares it doesn't already own in Japan's Chugai Pharmaceutical Co. . Shares of Chugai jumped 15% in...
The Economic Times  Aug 18  Comment 
The Nikkei was flat at 15,319.23 in a volatile mid-morning session after booking a 3.7 per cent gain last week, the biggest weekly rise since mid-April.
Reuters  Aug 17  Comment 
Chugai Pharmaceutical Co Ltd has denied a media report saying Roche Holding AG is in talks to buy the almost 40 percent stake in the Japanese company that it does not...





You may also be interested in articles related to Chugai Pharmaceuticals (4519-TO):
 
Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki